Literature DB >> 19257847

Understanding the regulation of Group B Streptococcal virulence factors.

Lakshmi Rajagopal1.   

Abstract

Bacterial infections remain a significant threat to the health of newborns and adults. Group B Streptococci (GBS) are Gram-positive bacteria that are common asymptomatic colonizers of healthy adults. However, this opportunistic organism can also subvert suboptimal host defenses to cause severe invasive disease and tissue damage. The increasing emergence of antibiotic-resistant GBS raises more concerns for sustained measures in treatment of the disease. A number of factors that are important for virulence of GBS have been identified. This review summarizes the functions of some well-characterized virulence factors, with an emphasis on how GBS regulates their expression. Regulatory and signaling molecules are attractive drug targets in the treatment of bacterial infections. Consequently, understanding signaling responses of GBS is essential for elucidation of pathogenesis of GBS infection and for the identification of novel therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19257847      PMCID: PMC2691590          DOI: 10.2217/17460913.4.2.201

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  178 in total

1.  Variation in the group B Streptococcus CsrRS regulon and effects on pathogenicity.

Authors:  Sheng-Mei Jiang; Nadeeza Ishmael; Julie Dunning Hotopp; Manuela Puliti; Luciana Tissi; Nikhil Kumar; Michael J Cieslewicz; Hervé Tettelin; Michael R Wessels
Journal:  J Bacteriol       Date:  2008-01-18       Impact factor: 3.490

2.  Pilus backbone contributes to group B Streptococcus paracellular translocation through epithelial cells.

Authors:  Alfredo Pezzicoli; Isabella Santi; Peter Lauer; Roberto Rosini; Daniela Rinaudo; Guido Grandi; John L Telford; Marco Soriani
Journal:  J Infect Dis       Date:  2008-09-15       Impact factor: 5.226

3.  First molecular characterization of group B streptococci with reduced penicillin susceptibility.

Authors:  Kouji Kimura; Satowa Suzuki; Jun-ichi Wachino; Hiroshi Kurokawa; Kunikazu Yamane; Naohiro Shibata; Noriyuki Nagano; Haru Kato; Keigo Shibayama; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-05-19       Impact factor: 5.191

4.  Sortase A utilizes an ancillary protein anchor for efficient cell wall anchoring of pili in Streptococcus agalactiae.

Authors:  Angela H Nobbs; Roberto Rosini; C Daniela Rinaudo; Domenico Maione; Guido Grandi; John L Telford
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441

5.  Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.

Authors:  Samira Dahesh; Mary E Hensler; Nina M Van Sorge; Robert E Gertz; Stephanie Schrag; Victor Nizet; Bernard W Beall
Journal:  Antimicrob Agents Chemother       Date:  2008-06-09       Impact factor: 5.191

6.  A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence.

Authors:  Heather C Maisey; Darin Quach; Mary E Hensler; George Y Liu; Richard L Gallo; Victor Nizet; Kelly S Doran
Journal:  FASEB J       Date:  2008-01-15       Impact factor: 5.191

7.  Interactions of the streptococcal C5a peptidase with human fibronectin.

Authors:  James R Hull; Glen S Tamura; David G Castner
Journal:  Acta Biomater       Date:  2008-02-01       Impact factor: 8.947

Review 8.  Penicillin-binding proteins and beta-lactam resistance.

Authors:  André Zapun; Carlos Contreras-Martel; Thierry Vernet
Journal:  FEMS Microbiol Rev       Date:  2008-01-29       Impact factor: 16.408

9.  Remodeling of the Streptococcus agalactiae transcriptome in response to growth temperature.

Authors:  Laurent Mereghetti; Izabela Sitkiewicz; Nicole M Green; James M Musser
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

10.  Group B streptococcal beta-hemolysin/cytolysin directly impairs cardiomyocyte viability and function.

Authors:  Mary E Hensler; Shigeki Miyamoto; Victor Nizet
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  61 in total

Review 1.  Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project.

Authors:  J Rodriguez-Granger; J C Alvargonzalez; A Berardi; R Berner; M Kunze; M Hufnagel; P Melin; A Decheva; G Orefici; C Poyart; J Telford; A Efstratiou; M Killian; P Krizova; L Baldassarri; B Spellerberg; A Puertas; M Rosa-Fraile
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09       Impact factor: 3.267

2.  Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis.

Authors:  Wolfgang Ernst; Nicole Zimara; Frank Hanses; Daniela N Männel; Birgit Seelbach-Göbel; Anja K Wege
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

3.  The sensor histidine kinase RgfC affects group B streptococcal virulence factor expression independent of its response regulator RgfA.

Authors:  Claire Gendrin; Annalisa Lembo; Christopher Whidbey; Kellie Burnside; Jessica Berry; Lisa Ngo; Anirban Banerjee; Liang Xue; Justine Arrington; Kelly S Doran; W Andy Tao; Lakshmi Rajagopal
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

4.  Complete genome sequence of Streptococcus agalactiae GD201008-001, isolated in China from tilapia with meningoencephalitis.

Authors:  Guangjin Liu; Wei Zhang; Chengping Lu
Journal:  J Bacteriol       Date:  2012-12       Impact factor: 3.490

5.  Group B Streptococcus induces a caspase-dependent apoptosis in fetal rat lung interstitium.

Authors:  David E Kling; Inna Tsvang; Miriam P Murphy; David S Newburg
Journal:  Microb Pathog       Date:  2013-04-25       Impact factor: 3.738

6.  Differing mechanisms of surviving phagosomal stress among group B Streptococcus strains of varying genotypes.

Authors:  Michelle L Korir; Clare Laut; Lisa M Rogers; Jessica A Plemmons; David M Aronoff; Shannon D Manning
Journal:  Virulence       Date:  2016-10-28       Impact factor: 5.882

7.  Two novel functions of hyaluronidase from Streptococcus agalactiae are enhanced intracellular survival and inhibition of proinflammatory cytokine expression.

Authors:  Zhaofei Wang; Changming Guo; Yannan Xu; Guangjin Liu; Chengping Lu; Yongjie Liu
Journal:  Infect Immun       Date:  2014-04-07       Impact factor: 3.441

8.  Serine/threonine phosphatase Stp1 mediates post-transcriptional regulation of hemolysin, autolysis, and virulence of group B Streptococcus.

Authors:  Kellie Burnside; Annalisa Lembo; Maria Isabel Harrell; Michael Gurney; Liang Xue; Nguyen-Thao BinhTran; James E Connelly; Kelsea A Jewell; Byron Z Schmidt; Melissa de Los Reyes; Weiguo Andy Tao; Kelly S Doran; Lakshmi Rajagopal
Journal:  J Biol Chem       Date:  2011-11-11       Impact factor: 5.157

9.  Regulation of hemolysin expression and virulence of Staphylococcus aureus by a serine/threonine kinase and phosphatase.

Authors:  Kellie Burnside; Annalisa Lembo; Melissa de Los Reyes; Anton Iliuk; Nguyen-Thao Binhtran; James E Connelly; Wan-Jung Lin; Byron Z Schmidt; Anthony R Richardson; Ferric C Fang; Weiguo Andy Tao; Lakshmi Rajagopal
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

10.  The Novel Streptococcal Transcriptional Regulator XtgS Negatively Regulates Bacterial Virulence and Directly Represses PseP Transcription.

Authors:  Guangjin Liu; Tingting Gao; Xiaojun Zhong; Jiale Ma; Yumin Zhang; Shiyu Zhang; Zongfu Wu; Zihao Pan; Yinchu Zhu; Huochun Yao; Yongjie Liu; Chengping Lu
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.